These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12723504)

  • 1. [How I treat...severe hypoglycemia in a diabetic patient].
    Radermecker RP; Philips JC; Scheen AJ
    Rev Med Liege; 2003 Mar; 58(3):119-22. PubMed ID: 12723504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypoglycemia--a dreaded complication of diabetes].
    Bjørgaas M
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2441-4. PubMed ID: 11475234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced disorders of glucose metabolism. Mechanisms and management.
    Chan JC; Cockram CS; Critchley JA
    Drug Saf; 1996 Aug; 15(2):135-57. PubMed ID: 8884164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
    Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypoglycemia in diabetes mellitus].
    Irsigler K
    Acta Med Austriaca; 1992; 19(4):100-5. PubMed ID: 1290316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycaemic valleys: an under-recognised problem in type 2 diabetes?
    Frier BM
    Int J Clin Pract Suppl; 2002 Jul; (129):12-9. PubMed ID: 12166599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia.
    Hope SV; Taylor PJ; Shields BM; Hattersley AT; Hamilton W
    Prim Care Diabetes; 2018 Apr; 12(2):139-146. PubMed ID: 28918198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and assessment of hypoglycemia in patients with diabetes mellitus].
    Scheen AJ
    Rev Med Liege; 2014 Feb; 69(2):110-5. PubMed ID: 24683833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypoglycemia in patients treated with an external insulin pump].
    Laurent JC; Waeber G; Ruiz J; Carron PN
    Rev Med Suisse; 2011 Jan; 7(278):166-9. PubMed ID: 21400952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.
    Lheureux PE; Zahir S; Penaloza A; Gris M
    Crit Care; 2005; 9(6):543-9. PubMed ID: 16356235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Symptoms and incidence of hypoglycemia in 100 insulin dependent diabetics].
    Gin H; Roulet M; Brottier E; Aubertin J
    Diabete Metab; 1984 Oct; 10(4):255-9. PubMed ID: 6510545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.
    Frier BM
    Nat Rev Endocrinol; 2014 Dec; 10(12):711-22. PubMed ID: 25287289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nasal glucagon (Baqsimi®), new treatment for hypoglycaemic coma].
    Philips JC; Radermecker RP; Lebrethon MC; S S
    Rev Med Liege; 2022 Sep; 77(9):538-543. PubMed ID: 36082602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypoglycaemic coma, a feared paroxysmal phenomenon in type 1 diabetic patient].
    Radermecker RP; Scheen AJ
    Rev Med Liege; 2004 May; 59(5):265-9. PubMed ID: 15264574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular or intravenous glucagon for sulphonylurea hypoglycaemia?
    Taylor JR; Sherratt HS; Davies DM
    Eur J Clin Pharmacol; 1978 Nov; 14(2):125-7. PubMed ID: 363433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylurea-induced hypoglycaemia: use of octreotide.
    Hanchard B; Boulouffe C; Vanpee D
    Acta Clin Belg; 2009; 64(1):56-8. PubMed ID: 19317242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin.
    Krentz AJ; Morrow L; Petersson M; Norjavaara E; Hompesch M
    Diabetes Obes Metab; 2014 Nov; 16(11):1096-101. PubMed ID: 24909093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.
    Shorr RI; Ray WA; Daugherty JR; Griffin MR
    Arch Intern Med; 1997 Aug 11-25; 157(15):1681-6. PubMed ID: 9250229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing awareness of hypoglycaemia in patients with type 2 diabetes treated with oral agents.
    Barnett AH; Brice R; Hanif W; James J; Langerman H
    Curr Med Res Opin; 2013 Nov; 29(11):1503-13. PubMed ID: 23952328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.